195 related articles for article (PubMed ID: 16983147)
1. Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol.
Pappu AS; Connor WE; Merkens LS; Jordan JM; Penfield JA; Illingworth DR; Steiner RD
J Lipid Res; 2006 Dec; 47(12):2789-98. PubMed ID: 16983147
[TBL] [Abstract][Full Text] [Related]
2. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
[TBL] [Abstract][Full Text] [Related]
3. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
4. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
[TBL] [Abstract][Full Text] [Related]
5. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.
Steiner RD; Linck LM; Flavell DP; Lin DS; Connor WE
J Lipid Res; 2000 Sep; 41(9):1437-47. PubMed ID: 10974051
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome.
Honda M; Tint GS; Honda A; Salen G; Shefer S; Batta AK; Matsuzaki Y; Tanaka N
J Inherit Metab Dis; 2000 Jul; 23(5):464-74. PubMed ID: 10947201
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.
Chan YM; Merkens LS; Connor WE; Roullet JB; Penfield JA; Jordan JM; Steiner RD; Jones PJ
Pediatr Res; 2009 Jun; 65(6):681-5. PubMed ID: 19430384
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency.
Jiang XS; Backlund PS; Wassif CA; Yergey AL; Porter FD
Mol Cell Proteomics; 2010 Jul; 9(7):1461-75. PubMed ID: 20305089
[TBL] [Abstract][Full Text] [Related]
9. Plasma plant sterol levels do not reflect cholesterol absorption in children with Smith-Lemli-Opitz syndrome.
Merkens LS; Jordan JM; Penfield JA; Lütjohann D; Connor WE; Steiner RD
J Pediatr; 2009 Apr; 154(4):557-561.e1. PubMed ID: 19101685
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome.
Starck L; Lövgren-Sandblom A; Björkhem I
J Intern Med; 2002 Oct; 252(4):314-21. PubMed ID: 12366604
[TBL] [Abstract][Full Text] [Related]
11. Intestinal absorption of cholesterol by patients with Smith-Lemli-Opitz syndrome.
Lin DS; Steiner RD; Flavell DP; Connor WE
Pediatr Res; 2005 Jun; 57(6):765-70. PubMed ID: 15774833
[TBL] [Abstract][Full Text] [Related]
12. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism.
Anderson AJ; Stephan MJ; Walker WO; Kelley RI
Am J Med Genet; 1998 Aug; 78(5):413-8. PubMed ID: 9714006
[TBL] [Abstract][Full Text] [Related]
13. Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome.
Tierney E; Conley SK; Goodwin H; Porter FD
Am J Med Genet A; 2010 Jan; 152A(1):91-5. PubMed ID: 20014133
[TBL] [Abstract][Full Text] [Related]
14. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.
Sikora DM; Ruggiero M; Petit-Kekel K; Merkens LS; Connor WE; Steiner RD
J Pediatr; 2004 Jun; 144(6):783-91. PubMed ID: 15192627
[TBL] [Abstract][Full Text] [Related]
16. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis.
Battaile KP; Steiner RD
Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806
[TBL] [Abstract][Full Text] [Related]
17. Dietary cholesterol supplementation and inhibitory factor 1 serum levels in two dizygotic Smith-Lemli-Opitz syndrome twins: a case report.
Delvecchio M; Rapone B; Simonetti S; Fecarotta S; De Carlo G; Favoino E; Loverro MT; Romano AMI; Taurino F; Di Naro E; Gnoni A
Ital J Pediatr; 2020 Oct; 46(1):161. PubMed ID: 33115520
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
[TBL] [Abstract][Full Text] [Related]
19. Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors.
Haas D; Niklowitz P; Hoffmann GF; Andler W; Menke T
Biofactors; 2008; 32(1-4):191-7. PubMed ID: 19096116
[TBL] [Abstract][Full Text] [Related]
20. Inborn errors of cholesterol biosynthesis.
Kelley RI
Adv Pediatr; 2000; 47():1-53. PubMed ID: 10959439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
